Parrella Health Law
By Christopher A. Parrella, Esq., CPC, CHC, CPCO
Boston, MA
A Health Care Provider Defense and Compliance Firm

Connecticut has now done something no state had directly done before: it has prohibited hospitals from entering into sale-leaseback transactions involving their main campus. That matters beyond Connecticut. It matters beyond hospitals.

The new law should be read as part of a broader regulatory shift. Legislators and regulators are no longer focused only on who owns a healthcare provider. They are increasingly focused on control: who controls the provider, who controls the real estate, who controls the cash, and whether financial arrangements interfere with clinical judgment or long-term operational stability.

Hospitals are the first target because the failures are visible, politically urgent, and devastating to communities. Other provider types should assume they may be next.

What Connecticut Did

On May 27, 2026, Connecticut Governor Ned Lamont signed Senate Bill 196 into law. The law imposes new restrictions on private equity involvement in hospitals and creates annual attestation obligations beginning February 15, 2027.

Hospitals must attest that no private equity entity has:

• A controlling interest in the hospital;
• Governance control or authority over the hospital’s main campus assets or operations; or
• Authority to require policies that interfere with clinician judgment or clinical decision-making.

Beginning July 1, 2027, the law also prohibits hospitals from entering into sale-leaseback transactions involving hospital-owned real property that constitutes the hospital’s main campus. In practical terms, Connecticut is saying that the operating hospital cannot be financially separated from its core real estate in a way that leaves the hospital dependent on rent obligations to a third party whose interests may not align with patient care or community access.

Why Sale-Leasebacks Are Under Fire

Sale-leasebacks are not automatically improper. In many industries, they are a legitimate financing tool. A company sells real estate, receives cash, and leases the property back. The transaction can unlock capital and support growth. But healthcare is different. When the real estate is a hospital’s main campus, the building is not just an asset. It is the platform for patient care. If rent obligations become unsustainable, the harm is not limited to investors or landlords. Patients, clinicians, employees, municipalities, and state governments feel the impact.

That is the policy concern driving Connecticut’s law. The Prospect Medical Holdings bankruptcy gave Connecticut lawmakers a real-world example. Prospect’s prior private equity ownership, real estate transactions, debt load, and operational deterioration became a focal point for legislators. The concern was not simply that a hospital failed. The concern was that financial engineering may have extracted value while leaving essential community hospitals weakened and dependent on public intervention.

Massachusetts Was the Warning Shot

Connecticut is not acting alone. Massachusetts moved aggressively after the Steward Health Care collapse. Its new law expanded oversight of healthcare transactions involving private equity firms, real estate investment trusts, and management services organizations. It also broadened review of material change transactions, including significant asset transfers and real estate sale-leaseback arrangements.

Massachusetts also restricted acute care hospital licensing where the main campus is leased from a healthcare real estate investment trust, subject to certain grandfathering protections. Connecticut has now gone further by directly prohibiting hospital sale-leasebacks involving the main campus. The trend is clear: states are building tools to examine healthcare transactions not only at the ownership level, but also at the level of financing, real estate control, management authority, and investor influence.

Why Other Provider Types Should Pay Attention

Hospitals are the first focus because they are large, essential, and politically significant. But the underlying concerns are not hospital-specific.

The same questions can be asked about behavioral health providers, substance use disorder treatment centers, autism service providers, physician practices, urgent care platforms, imaging centers, laboratories, and other healthcare businesses.

The Next Regulatory Frontier

In my opinion, the next wave of scrutiny will focus on control without formal ownership. That includes MSO agreements, investor consent rights, restrictive loan covenants, related-party leases, high management fees, real estate arrangements, and policies that influence clinical operations.

For behavioral health and SUD providers, this is especially important. These sectors already face scrutiny over medical necessity, length of stay, discharge planning, marketing, patient financial responsibility, and reimbursement practices. If regulators expand the hospital framework to other provider types, behavioral health will be an obvious target.

Bottom Line

Connecticut’s law is aimed at hospitals, but the message is broader. States are moving from passive transaction notice regimes to active oversight of healthcare capital structures. Sale-leasebacks, REIT relationships, MSO control rights, private equity governance rights, and investor influence over clinical operations are all moving into the regulatory spotlight. Hospitals are first because the public consequences of failure are immediate.

Other provider types should not assume they are exempt. For providers, the strategic takeaway is simple: capital is not the problem. Control is the problem. Any transaction that separates economic control from clinical responsibility should be carefully reviewed before it becomes the next legislative target.